10 mg ilaprazole

DRUG5 trials

Sponsors

Livzon Pharmaceutical Group Inc.

Conditions

Duodenal UlcerGastroesophageal Reflux Disease

Phase 2

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)

CompletedNCT00953381

Livzon Pharmaceutical Group Inc.Duodenal Ulcer

Start: 2004-10-31End: 2005-05-31Updated: 2009-08-06

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

Livzon Pharmaceutical Group Inc.Gastroesophageal Reflux Disease

Start: 2010-05-31Target: 330Updated: 2010-04-21

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients

CompletedNCT02847455

Livzon Pharmaceutical Group Inc.Duodenal Ulcer

Start: 2008-08-31Updated: 2016-07-28

Phase 3

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)

CompletedNCT00952978

Livzon Pharmaceutical Group Inc.Duodenal Ulcer

Start: 2005-09-30End: 2006-05-31Updated: 2009-08-06

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

CompletedNCT02860624

Livzon Pharmaceutical Group Inc.Gastroesophageal Reflux Disease

Start: 2011-12-31Updated: 2016-08-09

Related Papers

Cost-effectiveness analysis of Anaprazole versus Ilaprazole for the treatment of duodenal ulcers in China

Frontiers in Pharmacology2024-06-07

A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.

2016-12-016 citations

Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.

2012-01-0324 citations

A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.

2011-04-0126 citations